Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials-Reference-Cited by-同舟云学术

Single-agent DTIC versus combination chemotherapy with or without immunotherapy in metastatic melanoma: a meta-analysis of 3273 patients from 20 randomized trials

Published:2001-02 Issue:1 Volume:11 Page:75-81
ISSN:0960-8931
Container-title:Melanoma Research
language:en
Short-container-title:Melanoma Research

Author:

Huncharek M.,Caubet J. F.,McGarry R.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Dermatology,Oncology

Reference24 articles.

1. The rate of malignant melanoma in the United States: Are we making an impact?

2. Beta blockade during and after myocardial infarction: An overview of the randomized trials

3. Results of a randomized study comparing DTIC with TIC mustard in malignant melanoma

4. Multicenter randomized trial of dacarbazine alone or in combination with two different doses and schedules of interferon alfa-2a in the treatment of advanced melanoma.

Cited by 137 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Photothermal therapy improves the efficacy of topical immunotherapy against melanoma;Photodiagnosis and Photodynamic Therapy;2024-10

2. Photothermal Therapy Improves the Efficacy of Topical Immunotherapy Against Melanoma;2024

3. The role of dacarbazine and temozolomide therapy after treatment with immune checkpoint inhibitors in malignant melanoma patients: A case series and meta‐analysis;Pigment Cell & Melanoma Research;2023-12-29

4. The Distribution of B16 Melanoma Cells in Cell-Cycle Phases under the Influence of Dacarbazine;Cell and Tissue Biology;2023-04

5. Chemotherapy in Cutaneous Melanoma: Is There Still a Role?;Current Oncology Reports;2023-03-29